Picture of Veracyte logo

VCYT — Veracyte News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Veracyte Inc reports results for the quarter ended in March - Earnings Summary

* Veracyte Inc  VCYT.OQ  reported a quarterly adjusted loss
of 11
cents​​ per share for the quarter ended in March. The mean
expectation of nine analysts for the quarter was for a loss
of 13 cents per share.
    * Revenue rose 21.6% to $82.42 million from a year ago;
analysts
expected $75.81 million. 
    * Veracyte Inc's reported EPS for the quarter was a loss
of 11
cents​.
    * The mean earnings estimate of analysts had risen by
about 10.8%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Veracyte Inc shares had fallen by 3.5% this quarter and
lost 9.3% so far this year.
    * The company reported a quarterly loss of $8.09 million.
    * Wall Street's median 12-month price target for Veracyte
Inc is
$34.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
4 at 09:48 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.13          -0.11          Beat
 Dec. 31 2022      -0.15          -0.05          Beat
 Sep. 30 2022      -0.25          -0.12          Beat
 Jun. 30 2022      -0.22          -0.13          Beat

Recent news on Veracyte

See all news